Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
08/2004
08/17/2004CA2295861C Method of preparing a transgenic non-human animal expressing p25
08/17/2004CA2139681C Leaf cutter bee nest
08/12/2004WO2004067753A2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
08/12/2004WO2004067751A1 Use of regulatory sequences for specific, transient expression in neuronal determined cells
08/12/2004WO2004067746A1 Ires
08/12/2004WO2004067743A1 Vaccine production using transposon based vectors
08/12/2004WO2004067736A2 Custom-made meganuclease and use thereof
08/12/2004WO2004067707A2 Administration of transposon-based vectors to reproductive organs
08/12/2004WO2004067706A2 Production of multimeric proteins
08/12/2004WO2004067696A2 Interspecies embryonic stem cells
08/12/2004WO2004066909A2 Method for identifying novel treatments of inflammatory disease in the gut
08/12/2004WO2004066724A1 Transgenic animal having fatty acid desaturase and method of producing the same
08/12/2004WO2004015071A3 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
08/12/2004US20040158885 Chronic hepatitis virus infection and clonal hepatocellular carcinoma in mouse repopulated livers
08/12/2004US20040158883 Animal model for identification of modulators and treatments of obsessive-compulsive (OCD), attention deficit/hyperactivity (ADHD), mood, learning and sleep disorders
08/12/2004US20040158882 Novel vectors in avian transgenesis
08/12/2004US20040158881 Animal selected for lacking heparan sulfate 3-0-sulfotransferase-1 and uses thereof
08/12/2004US20040158879 Polynucleotide and polypeptide fat metabolism regulators and uses thereof
08/12/2004US20040158174 Method and apparatus for detecting lameness in animals
08/12/2004US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders
08/12/2004US20040157332 Using prokaryotic recombinase to initiate site specific insertion/deletion of extrachromosomal segments of DNA into eukaryotic genomes; gene therapy
08/12/2004US20040157324 Method for maintenance and propagation of germline stem cells using members of the TGF-beta family of growth factors
08/12/2004US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
08/12/2004US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor
08/12/2004US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease
08/12/2004US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
08/12/2004US20040157225 pharmaceuticals, kits and recombinant animal models for prognosis/prevention
08/12/2004US20040156848 Therapeutic uses of factors which inhibit or neutralize MIF activity
08/12/2004CA2514666A1 Ires
08/12/2004CA2514517A1 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
08/12/2004CA2514417A1 Custom-made meganuclease and use thereof
08/11/2004EP1444889A1 Transgenic animal
08/11/2004EP1444340A2 Transgenic mice knockout for histamine receptor h3 gene
08/11/2004EP1444254A2 Molecules for disease detection and treatment
08/11/2004EP1444245A2 Novel chromophores/fluorophores and methods for using the same
08/11/2004EP1443816A2 Methods of treating disorders related to apoe
08/11/2004EP1002080B9 Fluorescent proteins as cell-type specific reporter
08/11/2004EP0977859B1 The neurotrophic factor nnt-1
08/11/2004EP0862627B1 Neuropeptide y-y5 receptor
08/11/2004EP0730648B1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
08/11/2004CN2631220Y Feeding door of ant culturing case
08/11/2004CN1520459A Process for contructing mutant
08/11/2004CN1520424A Immunoglobulins 2
08/11/2004CN1520256A Use of follistatin to increase muscle mass
08/11/2004CN1161614C Corticotropin releasing factor receptor-1 deficient mice, and method of dertermination agonist agent and antagonist
08/10/2004US6774279 Use of FLP recombinase in mice
08/10/2004US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif)
08/10/2004US6773919 Transcription enhancers such as serine protease inhibitor-growth hormone responsive element
08/10/2004US6773914 PiggyBac transformation system
08/05/2004WO2004065558A2 Depletion of endogenous primordial germ cells in avian species
08/05/2004WO2004064768A2 Animal model for alzheimer's disease
08/05/2004WO2004064750A2 Improved constructs for expressing lysosomal polypeptides
08/05/2004WO2004064714A2 Animal model for obesity independently of insulin resistance
08/05/2004WO2004064500A2 Transcriptional coactivator asc-2
08/05/2004WO2004028243A3 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
08/05/2004WO2003063581A3 Compositions and methods for increasing animal size and growth rate
08/05/2004WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
08/05/2004US20040154049 Compounds
08/05/2004US20040154048 Activating nuclear transfered embryos via elevating cellular calcium levels and exposure to maturation promoting factor (MPF) inhibitor; artificial insemination and cloning; tissue engineering
08/05/2004US20040154047 Rodent animal model for use in identifying modulators for treatment of familial alzheimer's disease; targeted gene therapy
08/05/2004US20040154046 Gfp expression vector localized in mitochondria
08/05/2004US20040154045 Production of human recombinant collagen in the milk of transgenic animals
08/05/2004US20040152871 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders
08/05/2004US20040152637 To assess the risk of individuals to suffer from vascular contraction of coronary arteries in mammals; for therapy of vascular contraction of coronary arteries
08/05/2004US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems
08/05/2004US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering
08/05/2004US20040152088 Methods for diagnosing and treating heart disease
08/05/2004US20040151720 Cell surface molecule mediating cell adhesion and signal transmission
08/05/2004US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens
08/05/2004CA2513744A1 Depletion of endogenous primordial germ cells in avian species
08/04/2004EP1443111A1 Desmin gene having novel point mutation causative of dilated cardiomyopathy
08/04/2004EP1443107A1 Preparing somatic embryo by utilizing rabbit oocyte
08/04/2004EP1442658A1 Feed for elevating viral infection ratio in silkworm and method of viral inoculation using the feed
08/04/2004EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
08/04/2004CN1518596A Transgenic non-hyman animals for pharmacological and toxicological studies
08/04/2004CN1518559A VHH single heavy chain antibody and method for its preparation in mammal
08/04/2004CN1517009A Method for raising SPE hamster for preparing various biological products
08/03/2004US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death
08/03/2004US6770449 Methods of assaying receptor activity and constructs useful in such methods
07/2004
07/29/2004WO2004063890A2 Compact pedigree displays for heritable traits
07/29/2004WO2004063381A1 Targeted transgenesis using the rosa26 locus
07/29/2004WO2004063354A2 Compositions and methods for characterizing and regulating wnt pathways
07/29/2004WO2004063349A2 Lysozyme transgenic ungulates
07/29/2004WO2004063346A2 Lysozyme transgenic ungulates
07/29/2004WO2004063341A2 Hematopoietic stem cell niche cells
07/29/2004WO2004063127A1 Composter
07/29/2004WO2004062694A1 Devices and processes for distribution of genetic material to mammalian limb
07/29/2004WO2004062627A2 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders
07/29/2004WO2004062591A2 Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases
07/29/2004WO2004062474A2 Smooth muscle cell differentiation with crp, srf and gata factors
07/29/2004WO2004062360A1 Method of producing specific pathogen free hamster for the preparation of a variety of biological products
07/29/2004WO2004044156A3 Transgenic ungulates having reduced prion protein activity and uses thereof
07/29/2004WO2004021772A8 Immune cloning and uses thereof
07/29/2004WO2004020631A3 Genetic suppression and replacement
07/29/2004WO2003068915A3 Production of human antibodies in immunodeficient, non-human, mammalian hosts
07/29/2004WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof
07/29/2004US20040148648 for improved methods of in vitro/vivo re-cloning to improve transgene expression and expression levels in transgenic animals and production of healthier transgenic cells and/or animal models
07/29/2004US20040148646 Animals comprising human hepatocellular tissue
07/29/2004US20040148645 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor
07/29/2004US20040148644 Method for generating overexpression of alleles in genes of unknown function